Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas
Clinical trial NCT06120036 · COMPLETED
Trial details
- NCT number
- NCT06120036
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2025-01-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.